Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD

Soler Néstor, Torres Antoni

Source: Eur Respir J 2013; 41: 248-249
Journal Issue: January
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Soler Néstor, Torres Antoni. Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD. Eur Respir J 2013; 41: 248-249

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012



Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001

Sputum biomarkers in COPD exacerbations
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011

Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Microbiological indicators from sputum of patients with exacerbation of COPD
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


The BAL in the bacteriologic etiology in the COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

Prediction of imminent COPD exacerbations by sputum analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis
Source: International Congress 2017 – COPD and weaning
Year: 2017

Is sputum induction a safe procedure during COPD exacerbations?
Source: Eur Respir J 2007; 30: Suppl. 51, 183s
Year: 2007

Sputum colour as a marker of acute bacterial exacerbations of COPD
Source: Annual Congress 2003 - COPD - basic mechanisms and therapy of acute exacerbations
Year: 2003


Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
Source: Eur Respir Rev 2017; 26: 160073
Year: 2017



COPD: antibiotic strategy in infectious exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 137s
Year: 2001

Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis
Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021
Year: 2021



Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019



Definition and aetiology of infective exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 58-67
Year: 2013


Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Sputum bacteriology in acute COPD exacerbations: correlation with FEV1 deterioration
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001

An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004